Opko Health, Inc. Announces Successful Confirmation Of 4Kscore™ Algorithm In The United States

MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE:OPK) announced the successful completion of the calibration confirmation phase of the 4Kscore™ test clinical validation study currently underway at 21 urology clinics in the United States.